Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638462 · ClinicalTrials.gov registry record · NA
RIsE Stroke Mobility Study
A NA study, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07638462 is a NA study that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants.
The verdict
NCT07638462, a NA study, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is designed to better understand how patients with severe stroke move during their hospital stay. It will track their activity using a small wearable device (activPAL) along with standard mobility information already collected in clinical care. The goal is to learn what typical movement patterns look like early after a stroke and how well patients meet mobility goals while in the hospital. What is learned from this study may allow determination of how treatment for stroke patients may be improved to improve patient long-term mobility.
Interventions
- DEVICE activPAL device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-08 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07638462
The ClinicalTrials.gov registry entry for NCT07638462 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which activPAL device is the first listed.
NCT07638462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07638462 about?
NCT07638462 is a clinical study titled "RIsE Stroke Mobility Study". This study is designed to better understand how patients with severe stroke move during their hospital stay. It will track their activity using a small wearable device (activPAL) along with standard mobility information already collected in clinical care. The goal is to learn what typical movement p...
What is the current status of trial NCT07638462?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-08. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07638462?
The interventions under investigation include: activPAL device (DEVICE).
Who is sponsoring clinical trial NCT07638462?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.